Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

142 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The MDM2-p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced or Metastatic Solid Tumors: Results of a Phase Ia, First-in-Human, Dose-Escalation Study.
LoRusso P, Yamamoto N, Patel MR, Laurie SA, Bauer TM, Geng J, Davenport T, Teufel M, Li J, Lahmar M, Gounder MM. LoRusso P, et al. Among authors: gounder mm. Cancer Discov. 2023 Aug 4;13(8):1802-1813. doi: 10.1158/2159-8290.CD-23-0153. Cancer Discov. 2023. PMID: 37269344 Free PMC article. Clinical Trial.
Activity of Sorafenib against desmoid tumor/deep fibromatosis.
Gounder MM, Lefkowitz RA, Keohan ML, D'Adamo DR, Hameed M, Antonescu CR, Singer S, Stout K, Ahn L, Maki RG. Gounder MM, et al. Clin Cancer Res. 2011 Jun 15;17(12):4082-90. doi: 10.1158/1078-0432.CCR-10-3322. Epub 2011 Mar 29. Clin Cancer Res. 2011. PMID: 21447727 Free PMC article.
Moving forward one Notch at a time.
Gounder MM, Schwartz GK. Gounder MM, et al. J Clin Oncol. 2012 Jul 1;30(19):2291-3. doi: 10.1200/JCO.2012.42.3277. Epub 2012 May 7. J Clin Oncol. 2012. PMID: 22564999 No abstract available.
Phase II trial of the CDK4 inhibitor PD0332991 in patients with advanced CDK4-amplified well-differentiated or dedifferentiated liposarcoma.
Dickson MA, Tap WD, Keohan ML, D'Angelo SP, Gounder MM, Antonescu CR, Landa J, Qin LX, Rathbone DD, Condy MM, Ustoyev Y, Crago AM, Singer S, Schwartz GK. Dickson MA, et al. Among authors: gounder mm. J Clin Oncol. 2013 Jun 1;31(16):2024-8. doi: 10.1200/JCO.2012.46.5476. Epub 2013 Apr 8. J Clin Oncol. 2013. PMID: 23569312 Free PMC article. Clinical Trial.
High-risk features in radiation-associated breast angiosarcomas.
D'Angelo SP, Antonescu CR, Kuk D, Qin L, Moraco N, Carvajal RC, Chi P, Dickson MA, Gounder M, Keohan ML, Singer S, Schwartz GK, Tap WD. D'Angelo SP, et al. Among authors: gounder m. Br J Cancer. 2013 Oct 29;109(9):2340-6. doi: 10.1038/bjc.2013.590. Epub 2013 Oct 8. Br J Cancer. 2013. PMID: 24104962 Free PMC article.
A first-in-human phase I study of MORAb-004, a monoclonal antibody to endosialin in patients with advanced solid tumors.
Diaz LA Jr, Coughlin CM, Weil SC, Fishel J, Gounder MM, Lawrence S, Azad N, O'Shannessy DJ, Grasso L, Wustner J, Ebel W, Carvajal RD. Diaz LA Jr, et al. Among authors: gounder mm. Clin Cancer Res. 2015 Mar 15;21(6):1281-8. doi: 10.1158/1078-0432.CCR-14-1829. Epub 2014 Nov 14. Clin Cancer Res. 2015. PMID: 25398449 Free PMC article. Clinical Trial.
Outcomes of Systemic Therapy for Patients with Metastatic Angiosarcoma.
D'Angelo SP, Munhoz RR, Kuk D, Landa J, Hartley EW, Bonafede M, Dickson MA, Gounder M, Keohan ML, Crago AM, Antonescu CR, Tap WD. D'Angelo SP, et al. Among authors: gounder m. Oncology. 2015;89(4):205-14. doi: 10.1159/000381917. Epub 2015 Jun 3. Oncology. 2015. PMID: 26043723 Free PMC article.
Phase II Trial of Gemcitabine and Docetaxel with Bevacizumab in Soft Tissue Sarcoma.
Dickson MA, D'Adamo DR, Keohan ML, D'Angelo SP, Carvajal RD, Gounder MM, Maki RG, Qin LX, Lefkowitz RA, McKennon OR, Hirst CM, Schwartz GK, Tap WD. Dickson MA, et al. Among authors: gounder mm. Sarcoma. 2015;2015:532478. doi: 10.1155/2015/532478. Epub 2015 May 14. Sarcoma. 2015. PMID: 26074722 Free PMC article.
142 results